Multifunctional nanoparticles with anti-inflammatory effect for improving metabolic syndromes

References

• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12.
   PubMed Web of Science ®Google Scholar
• McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36(1):14–20.
   PubMed Web of Science ®Google Scholar
• Sherling DH, Perumareddi P, Hennekens CH. Metabolic syndrome: clinical and policy implications of the new silent killer. J Cardiovasc Pharmacol Ther. 2017;22(4):365–367.
   PubMed Web of Science ®Google Scholar
• Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1–23.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wan N, Shan X, et al. Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice. Acta Pharm Sin B. 2021;11(5):1200–1212.
   PubMed Web of Science ®Google Scholar
• Rochlani Y, Pothineni NV, Kovelamudi S, et al. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215–225.
   PubMedGoogle Scholar
• Hendrickx JO, van Gastel J, Leysen H, et al. High-dimensionality data analysis of pharmacological systems associated with complex diseases. Pharmacol Rev. 2020;72(1):191–217.
   PubMed Web of Science ®Google Scholar
• Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096–1103.
   PubMed Web of Science ®Google Scholar
• Sun L, Pang Y, Wang X, et al. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. Acta Pharm Sin B. 2019;9(4):702–710.
   PubMed Web of Science ®Google Scholar
• Pucci G, Alcidi R, Tap L, et al. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34–42.
   PubMed Web of Science ®Google Scholar
• Mogilenko DA, Haas JT, L’Homme L, et al. Metabolic and innate immune cues merge into a specific inflammatory response via the UPR. Cell. 2019;177(5):1201–1216.e19.
   PubMed Web of Science ®Google Scholar
• Gluvic Z, Zaric B, Resanovic I, et al. Link between metabolic syndrome and insulin resistance. Curr Vasc Pharmacol. 2017;15(1):30–39.
   PubMed Web of Science ®Google Scholar
• Hong C, Liang J, Xia J, et al. One stone four birds: a novel liposomal delivery system multi-functionalized with ginsenoside Rh2 for tumor targeting therapy. Nanomicro Lett. 2020;12(1):129.
   PubMed Web of Science ®Google Scholar
• Shin DM. Application of nanotechnology in cancer therapy and imaging [meeting abstract]. Drug Metab Rev. 2010;42:13–13.
   Web of Science ®Google Scholar
• Wang X, Yang L, Chen ZG, et al. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin. 2008;58(2):97–110.
   PubMed Web of Science ®Google Scholar
• Fan Y, Marioli M, Zhang K. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery. J Pharm Biomed Anal. 2021;192:113642.
   PubMed Web of Science ®Google Scholar
• Chen Q, Guo C, Zhou X, et al. N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H(2)S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis. Int J Biol Macromol. 2022;211:259–270.
   PubMed Web of Science ®Google Scholar
• Sercombe L, Veerati T, Moheimani F, et al. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.
   PubMed Web of Science ®Google Scholar
• Blenke EO, Mastrobattista E, Schiffelers RM. Strategies for triggered drug release from tumor targeted liposomes [review]. Expert Opin Drug Deliv. 2013;10(10):1399–1410.
   PubMed Web of Science ®Google Scholar
• Li T, Cipolla D, Rades T, et al. Drug nanocrystallisation within liposomes. J Control Release. 2018;288:96–110.
   PubMed Web of Science ®Google Scholar
• Riaz MK, Riaz MA, Zhang X, et al. Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. Int J Mol Sci. 2018;19(1):195.
   Web of Science ®Google Scholar
• Xia J, Ma S, Zhu X, et al. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches. Sci Adv. 2022;8(6):eabj1262.
   PubMed Web of Science ®Google Scholar
• Alberts DS, Garcia DJ. Safety aspects of pegylated liposomal doxorubicin in patients with cancer. Drugs. 1997;54(Suppl 4):30–35.
   PubMed Web of Science ®Google Scholar
• Skubitz KM, Skubitz AP. Mechanism of transient dyspnea induced by pegylated-liposomal doxorubicin (doxil). Anticancer Drugs. 1998;9(1):45–50.
   PubMed Web of Science ®Google Scholar
• Levine SJ, Walsh TJ, Martinez A, et al. Cardiopulmonary toxicity after liposomal amphotericin B infusion. Ann Intern Med. 1991;114(8):664–666.
   PubMed Web of Science ®Google Scholar
• Uziely B, Jeffers S, Isacson R, et al. Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol. 1995;13(7):1777–1785.
   PubMed Web of Science ®Google Scholar
• Szebeni J, Baranyi L, Savay S, et al. Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am J Physiol Heart Circ Physiol. 2000;279(3):H1319–28.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs. 1997;54(Suppl 4):15–21.
   PubMed Web of Science ®Google Scholar
• Moein Moghimi S, Hamad I, Bünger R, et al. Activation of the human complement system by cholesterol-rich and PEGylated liposomes-modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels. J Liposome Res. 2006;16(3):167–174.
   PubMed Web of Science ®Google Scholar
• Sonawane PD, Pollier J, Panda S, et al. Plant cholesterol biosynthetic pathway overlaps with phytosterol metabolism. Nat Plants. 2016;3:16205.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lin K, Li Y. Highlights to phytosterols accumulation and equilibrium in plants: biosynthetic pathway and feedback regulation. Plant Physiol Biochem. 2020;155:637–649.
   PubMed Web of Science ®Google Scholar
• Grosjean K, Mongrand S, Beney L, et al. Differential effect of plant lipids on membrane organization: specificities of phytosphingolipids and phytosterols. J Biol Chem. 2015;290(9):5810–5825.
   PubMed Web of Science ®Google Scholar
• Man Z, Ke-Xin K, Lu X, et al. Research progress on biosynthesis of phytosterols and their derivatives. Chin Tradition Herb Drugs. 2022;53(18):5884–5898.
   Google Scholar
• Li X, Xin Y, Mo Y, et al. The bioavailability and biological activities of phytosterols as modulators of cholesterol metabolism. Molecules. 2022;27(2):523.
   PubMed Web of Science ®Google Scholar
• Yu C, Liu H, Guo C, et al. Dextran sulfate-based MMP-2 enzyme-sensitive SR-a receptor targeting nanomicelles for the treatment of rheumatoid arthritis. Drug Deliv. 2022;29(1):454–465.
   PubMed Web of Science ®Google Scholar
• Chen Q, Guo C, Guo H, et al. Celestrol-Loaded nanoscale micelles derived from dextran sulfate/PVGLIG/celestrol with MMP-2 sensitivity for the treatment of High-Fat-Diet-Induced obesity. ACS Appl Nano Mater. 2022;5(9):13236–13244.
   Web of Science ®Google Scholar
• Shen S, Xu X, Lin S, et al. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. Nat Nanotechnol. 2021;16(1):104–113.
   PubMed Web of Science ®Google Scholar
• Yu H, Jin F, Liu D, et al. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics. 2020;10(5):2342–2357.
   PubMed Web of Science ®Google Scholar
• Li Y, Guo C, Chen Q, et al. Improvement of pneumonia by curcumin-loaded bionanosystems based on platycodon grandiflorum polysaccharides via calming cytokine storm. Int J Biol Macromol. 2022;202:691–706.
   PubMed Web of Science ®Google Scholar